Skip to main content
. 2024 Jan 26;6(2):33–41. doi: 10.37737/ace.24006

Fig. 3 . Primary outcome: factors associated with tolvaptan dose reduction or discontinuation.

Fig. 3

Abbreviations: eGFR, estimated Glomerular Filtration Rate; DM, Diabetes Mellitus; HT, Hypertension; HRs, Hazard Ratios; CI, Confidence Interval; CKD, Chronic Kidney Disease